CSPC Pharmaceutical Group Ltd (CHJTF)
0.85
+0.10
(+13.33%)
USD |
OTCM |
May 17, 16:00
CSPC Pharmaceutical Group Total Liabilities (Quarterly): 1.589B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.589B |
| June 30, 2023 | 1.401B |
| June 30, 2023 | 1.401B |
| December 31, 2022 | 1.468B |
| June 30, 2022 | 1.406B |
| December 31, 2021 | 1.241B |
| June 30, 2021 | 1.167B |
| June 30, 2021 | 1.167B |
| December 31, 2020 | 1.067B |
| June 30, 2020 | 1.193B |
| June 30, 2020 | 1.193B |
| December 31, 2019 | 971.89M |
| June 30, 2019 | 988.33M |
| June 30, 2019 | 988.33M |
| December 31, 2018 | 1.117B |
| June 30, 2018 | 1.170B |
| June 30, 2018 | 1.170B |
| December 31, 2017 | 785.62M |
| June 30, 2017 | 711.87M |
| June 30, 2017 | 711.87M |
| Date | Value |
|---|---|
| December 31, 2016 | 589.03M |
| June 30, 2016 | 660.33M |
| June 30, 2016 | 660.33M |
| December 31, 2015 | 609.77M |
| June 30, 2015 | 682.88M |
| June 30, 2015 | 682.88M |
| December 31, 2014 | 560.72M |
| June 30, 2014 | 593.88M |
| June 30, 2014 | 593.88M |
| December 31, 2013 | 593.61M |
| June 30, 2013 | 740.19M |
| June 30, 2013 | 740.19M |
| December 31, 2012 | 894.61M |
| June 30, 2012 | 580.62M |
| December 31, 2011 | 185.16M |
| June 30, 2011 | 563.21M |
| December 31, 2010 | 138.43M |
| June 30, 2010 | 485.77M |
| December 31, 2009 | 467.66M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
971.89M
Minimum
Dec 2019
1.589B
Maximum
Dec 2023
1.232B
Average
1.193B
Median
Jun 2020
Total Liabilities (Quarterly) Benchmarks
| Sinovac Biotech Ltd | 1.635B |
| CASI Pharmaceuticals Inc | 51.10M |
| Zai Lab Ltd | 226.27M |
| Gracell Biotechnologies Inc (DELISTED) | 36.85M |
| Adagene Inc | 45.17M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.529B |
| Shareholders Equity (Quarterly) | 4.684B |
| Debt to Equity Ratio | 0.0136 |
| Current Ratio | 2.626 |
| Net Debt Paydown Yield | -0.13% |